9 Meters Biopharma Inc reports results for the quarter ended in March - Earnings Summary

9 Meters Biopharma

13/05/2021 20:47

* 9 Meters Biopharma Inc  NMTR.OQ  reported a quarterly adjusted
loss of 3 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 3 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* 9 Meters Biopharma Inc's reported EPS for the quarter was a
loss of 3 cents​.
* The mean earnings estimate of analysts had risen by
about 31.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* 9 Meters Biopharma Inc shares had fallen by 6.0% this
quarter and gained 28.1% so far this year.
* The company reported a quarterly loss of $5.43 million.
* Wall Street's median 12-month price target for 9 Meters
Biopharma Inc is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 07:47 p.m. GMT.
​All figures in US dollars